Tudor Investment Corp ET AL Makes New $1.54 Million Investment in Liquidia Corporation $LQDA

Tudor Investment Corp ET AL bought a new position in shares of Liquidia Corporation (NASDAQ:LQDA) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 67,557 shares of the company’s stock, valued at approximately $1,536,000. Tudor Investment Corp ET AL owned 0.08% of Liquidia as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors also recently modified their holdings of LQDA. Whitcomb & Hess Inc. boosted its holdings in shares of Liquidia by 2.0% in the 3rd quarter. Whitcomb & Hess Inc. now owns 28,385 shares of the company’s stock valued at $645,000 after buying an additional 558 shares during the period. Alliancebernstein L.P. raised its stake in Liquidia by 1.4% during the third quarter. Alliancebernstein L.P. now owns 67,050 shares of the company’s stock worth $1,525,000 after acquiring an additional 900 shares during the period. Steward Partners Investment Advisory LLC lifted its holdings in Liquidia by 24.0% in the second quarter. Steward Partners Investment Advisory LLC now owns 6,200 shares of the company’s stock worth $77,000 after acquiring an additional 1,200 shares during the last quarter. Skandinaviska Enskilda Banken AB publ bought a new position in Liquidia in the third quarter worth about $30,000. Finally, Creative Planning boosted its stake in Liquidia by 5.4% in the third quarter. Creative Planning now owns 28,298 shares of the company’s stock valued at $643,000 after acquiring an additional 1,458 shares during the period. 64.54% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities analysts have recently commented on LQDA shares. Wall Street Zen raised Liquidia from a “hold” rating to a “buy” rating in a report on Saturday, March 7th. HC Wainwright boosted their price objective on Liquidia from $50.00 to $55.00 and gave the company a “buy” rating in a research report on Friday, March 6th. Wells Fargo & Company upped their price objective on Liquidia from $44.00 to $51.00 and gave the stock an “overweight” rating in a research note on Monday, March 23rd. Raymond James Financial reaffirmed a “strong-buy” rating on shares of Liquidia in a research report on Thursday, March 5th. Finally, Needham & Company LLC raised their target price on Liquidia from $52.00 to $54.00 and gave the company a “buy” rating in a research note on Thursday, March 5th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, one has issued a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $43.44.

Insider Activity at Liquidia

In other news, CFO Michael Kaseta sold 36,932 shares of the stock in a transaction on Monday, January 12th. The stock was sold at an average price of $37.43, for a total value of $1,382,364.76. Following the completion of the transaction, the chief financial officer owned 350,919 shares of the company’s stock, valued at approximately $13,134,898.17. This represents a 9.52% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Roger Jeffs sold 66,610 shares of the firm’s stock in a transaction on Monday, January 12th. The shares were sold at an average price of $37.43, for a total value of $2,493,212.30. Following the transaction, the chief executive officer directly owned 1,037,528 shares in the company, valued at $38,834,673.04. This trade represents a 6.03% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 230,848 shares of company stock worth $8,638,491 in the last ninety days. 26.50% of the stock is currently owned by corporate insiders.

Liquidia Stock Performance

LQDA opened at $35.03 on Monday. The business’s 50 day moving average is $37.64 and its 200-day moving average is $31.88. The stock has a market cap of $3.09 billion, a PE ratio of -42.20 and a beta of 0.52. The company has a current ratio of 2.01, a quick ratio of 1.84 and a debt-to-equity ratio of 2.97. Liquidia Corporation has a twelve month low of $11.26 and a twelve month high of $46.67.

Liquidia (NASDAQ:LQDA) last issued its quarterly earnings data on Thursday, March 5th. The company reported $0.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.08 by $0.07. Liquidia had a negative return on equity of 209.33% and a negative net margin of 43.53%.The business had revenue of $92.02 million during the quarter, compared to analyst estimates of $87.49 million. Liquidia’s revenue for the quarter was up 3072.4% compared to the same quarter last year. On average, analysts predict that Liquidia Corporation will post -1.51 earnings per share for the current year.

Liquidia Company Profile

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).